1. And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?

   • Kai M. Beeh

   Editorial Open access 25 July 2018 Pages: 115 - 119

2. COPD and Singing for Lung Health: A Patient and Clinician Perspective

   • Adam Lewis
   • John Thomas

   Commentary Open access 07 September 2018 Pages: 121 - 124

3. Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines

   • Mohamed E. A. Abdelrahim

   Commentary Open access 31 July 2018 Pages: 125 - 133

   

4. Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database

   • Ryo Atsuta
   • Jun Takai
   • Henrik Svedsater

   Original Research Open access 30 October 2018 Pages: 135 - 147

   

5. Home Management of Childhood Asthma Exacerbations

   • Telford Y. Yeung
   • Christopher Ewing
   • Israel Amirav

   Original Research Open access 31 August 2018 Pages: 149 - 157

6. Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial

   • Hiroyuki Ohbayashi
   • Sahori Kudo
   • Mitsue Ariga

   Original Research Open access 07 September 2018 Pages: 159 - 169

   

7. Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

   • Bernardino Alcázar Navarrete
   • Isabelle Boucot
   • Gregory Feldman

   Original Research Open access 20 June 2018 Pages: 171 - 183